Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro

References

• World Health Organization. Ebola virus diease: key facts. Geneva: 2020.
   Google Scholar
• Gomes MF, et al. Assessing the international spreading risk associated with the 2014 west african ebola outbreak. PLoS Curr. 2014;6:1–11.
   Google Scholar
• Ascenzi P, Bocedi A, Heptonstall J, et al. Ebolavirus and marburgvirus: insight the Filoviridae family. Mol Aspects Med. 2008;29(3):151–185.
   PubMed Web of Science ®Google Scholar
• Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet. 2011;377(9768):849–862.
   PubMed Web of Science ®Google Scholar
• Haque A, Hober D, Blondiaux J. Addressing therapeutic options for Ebola virus infection in current and future outbreaks. Antimicrob Agents Chemother. 2015;59(10):5892–5902.
   PubMed Web of Science ®Google Scholar
• Cardile AP, Mayers DL, Bavari S. Current status of chemically synthesized inhibitors of Ebola virus. Recent Pat Antiinfect Drug Discov. 2015;9(2):97–103.
   Google Scholar
• Kaufmann SHE, Dorhoi A, Hotchkiss RS, et al. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018;17(1):35–56.
   PubMed Web of Science ®Google Scholar
• Saeed MF, Kolokoltsov AA, Albrecht T, et al. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 2010;6(9):e1001110.
   PubMed Web of Science ®Google Scholar
• Carette JE, Raaben M, Wong AC, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011;477(7364):340–343.
   PubMed Web of Science ®Google Scholar
• Miller EH, Obernosterer G, Raaben M, et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 2012;31(8):1947–1960.
   PubMed Web of Science ®Google Scholar
• Hoglinger D, Burgoyne T, Sanchez-Heras E, et al. NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress. Nat Commun. 2019;10(1):4276.
   PubMed Web of Science ®Google Scholar
• Cote M, Misasi J, Ren T, et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature. 2011;477(7364):344–348.
   PubMed Web of Science ®Google Scholar
• Flemming A. Achilles heel of Ebola viral entry. Nat Rev Drug Discov. 2011;10(10):731.
   PubMed Web of Science ®Google Scholar
• Lu F, et al. Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. Elife. 2015;4:e12177.
   PubMed Web of Science ®Google Scholar
• Amritraj A, Wang Y, Revett TJ, et al. Role of cathepsin D in U18666A-induced neuronal cell death: potential implication in Niemann-Pick type C disease pathogenesis. J Biol Chem. 2013;288(5):3136–3152.
   PubMed Web of Science ®Google Scholar
• Schloer S, Brunotte L, Goretzko J, et al. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Emerg Microbes Infect. 2020;9(1):2245–2255.
   PubMed Web of Science ®Google Scholar
• Schloer S, Goretzko J, Kühnl A, et al. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerg Microbes Infect. 2019;8(1):80–93.
   PubMed Web of Science ®Google Scholar
• Schloer S, Goretzko J, Pleschka S, et al. Combinatory treatment with oseltamivir and itraconazole targeting both virus and host factors in Influenza A virus infection. Viruses. 2020;12(7):703.
   PubMed Web of Science ®Google Scholar
• Lawko N, et al. 3D tissue models as an effective tool for studying viruses and vaccine development. Front Mater. 2021;8(80):631373.
   Web of Science ®Google Scholar
• Bokelmann M, Edenborough K, Hetzelt N, et al. Utility of primary cells to examine NPC1 receptor expression in Mops condylurus, a potential Ebola virus reservoir. PLoS Negl Trop Dis. 2020;14(1):e0007952.
   PubMed Web of Science ®Google Scholar
• Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51(5):1417–1423.
   PubMedGoogle Scholar
• Long T, Qi X, Hassan A, et al. Structural basis for itraconazole-mediated NPC1 inhibition. Nat Commun. 2020;11(1):152.
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Tripal P, Reichel M, et al. Functional inhibitors of acid sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem. 2010;26(1):9–20.
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27(3):493–497.
   Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671–675.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993;169(3):375–382.
   PubMed Web of Science ®Google Scholar
• Zhu L, Hu X, Kumar D, et al. Both ganglioside GM2 and cholesterol in the cell membrane are essential for bombyx mori cypovirus cell entry. Dev Comp Immunol. 2018;88:161–168.
   PubMed Web of Science ®Google Scholar
• Kuhnl A, Musiol A, Heitzig N, et al. Late endosomal/lysosomal cholesterol accumulation Is a host cell-protective mechanism inhibiting endosomal escape of Influenza A virus. mBio. 2018;9(4):e01345–18.
   PubMed Web of Science ®Google Scholar
• Johnson DE, Ostrowski P, Jaumouillé V, et al. The position of lysosomes within the cell determines their luminal pH. J Cell Biol. 2016;212(6):677–692.
   PubMed Web of Science ®Google Scholar
• Killington HA. Virology methods manual. London; San Diego: Academic Press; 1996; p. 374.
   Google Scholar
• Faul F, Erdfelder E, Lang A-G, et al. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–191.
   PubMed Web of Science ®Google Scholar
• Bergy ME, Eble TE. Filipin complex. Biochemistry. 1968;7(2):653–659.
   PubMed Web of Science ®Google Scholar
• Karakuzu O, Cruz M, Liu Y, et al. Amplex Red assay for measuring hydrogen peroxide production from caenorhabditis elegans. Bio Protoc. 2019;9(21):e3409.
   PubMed Web of Science ®Google Scholar
• Moller-Tank S, Maury W. Ebola virus entry: a curious and complex series of events. PLoS Pathog. 2015;11(4):e1004731.
   PubMed Web of Science ®Google Scholar
• Schloer S, Brunotte L, Mecate-Zambrano A, et al. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro. Br J Pharmacol. 2021;178(11):2339–2350.
   PubMed Web of Science ®Google Scholar
• Goldstein T, Anthony SJ, Gbakima A, et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat Microbiol. 2018;3(10):1084–1089.
   PubMed Web of Science ®Google Scholar
• Herbert AS, Davidson C, Kuehne AI, et al. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. mBio. 2015;6(3):e00565–15.
   PubMed Web of Science ®Google Scholar
• Bavari S, Bosio CM, Wiegand E, et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med. 2002;195(5):593–602.
   PubMed Web of Science ®Google Scholar
• White JM, Whittaker GR. Fusion of enveloped viruses in endosomes. Traffic. 2016;17(6):593–614.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Warfield KL, Ruthel G, et al. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology. 2010;401(1):18–28.
   PubMed Web of Science ®Google Scholar
• Lee JE, Saphire EO. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 2009;4(6):621–635.
   PubMed Web of Science ®Google Scholar
• Chandran K, Sullivan NJ, Felbor U, et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005;308(5728):1643–1645.
   PubMed Web of Science ®Google Scholar
• Schornberg K, Matsuyama S, Kabsch K, et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol. 2006;80(8):4174–4178.
   PubMed Web of Science ®Google Scholar
• Mercer J, Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science. 2008;320(5875):531–535.
   PubMed Web of Science ®Google Scholar
• Koivusalo M, Matsuyama S, Kabsch K, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188(4):547–563.
   PubMed Web of Science ®Google Scholar
• Nanbo A, Imai M, Watanabe S, et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 2010;6(9):e1001121.
   PubMed Web of Science ®Google Scholar
• Bosworth A, Dowall SD, Garcia-Dorival I, et al. A comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus. Sci Rep. 2017;7:43144.
   PubMed Web of Science ®Google Scholar
• Kotliar D, Lin AE, Logue J, et al. Single-cell profiling of Ebola virus disease In vivo reveals viral and host dynamics. Cell. 2020;183(5):1383–1401.e19.
   PubMed Web of Science ®Google Scholar
• Stewart CM, Phan A, Bo Y, et al. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments. PLoS Pathog. 2021;17(1):e1009275.
   PubMed Web of Science ®Google Scholar
• Tsubamoto H, Inoue K, Sakata K, et al. Itraconazole inhibits AKT/mTOR signaling and proliferation in endometrial cancer cells. Anticancer Res. 2017;37(2):515–520.
   PubMed Web of Science ®Google Scholar
• Wang W, Dong X, Liu Y, et al. Itraconazole exerts anti-liver cancer potential through the Wnt, PI3K/AKT/mTOR, and ROS pathways. Biomed Pharmacother. 2020;131:110661.
   PubMed Web of Science ®Google Scholar
• Nacev BA, Grassi P, Dell A, et al. The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells. J Biol Chem. 2011;286(51):44045–44056.
   PubMed Web of Science ®Google Scholar
• Mullard A. FDA approves antibody cocktail for Ebola virus. Nat Rev Drug Discov. 2020;19(12):827.
   Web of Science ®Google Scholar
• Sánchez AD-GHSNJG. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions. Clin Microbiol Infect. 2006;12(suppl. 7):97–106.
   PubMedGoogle Scholar
• Glasmacher A, Prentice AG. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies. J Antimicrob Chemother. 2005;56(Suppl. 1):i23–i32.
   PubMed Web of Science ®Google Scholar
• Lestner J, Hope WW. Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opin Drug Metab Toxicol. 2013;9(7):911–926.
   PubMed Web of Science ®Google Scholar
• Shin JH, Choi KY, Kim YC, et al. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect. Antimicrob Agents Chemother. 2004;48(5):1756–1762.
   PubMed Web of Science ®Google Scholar
• Pope S, Zaraa SG. Efficacy of long-acting injectable antipsychotics in adolescents. J Child Adolesc Psychopharmacol. 2016;26(4):391–394.
   PubMed Web of Science ®Google Scholar
• Preskorn SH, Fast GA. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry. 1991;52(Suppl.):23–33.
   PubMedGoogle Scholar